Routine Or Selective Application of a Face Mask for Preterm Infants at Birth: the ROSA Trial
ROSA
A Randomised Trial of Routine or Selective Application of a Face Mask for Preterm Infants at Birth
1 other identifier
interventional
201
1 country
1
Brief Summary
International guidelines recommend giving positive pressure ventilation (PPV) by face mask to newborns who do not breathe or have a slow heart rate at birth. Preterm infants are at high risk of developing respiratory distress syndrome (RDS) and many are treated with continuous positive airway pressure (CPAP) in the neonatal intensive care unit (NICU). Though the majority of preterm infants breathe spontaneously at birth, many clinicians routinely apply a face mask to preterm infants shortly after birth in the delivery room (DR) to give them CPAP. However, applying a face mask may inhibit spontaneous breathing in newborns. In this study, premature babies will be randomly assigned to have a face mask routinely applied for CPAP shortly after birth; or to have a face mask selectively applied only for PPV if they are not breathing or have a slow heart beat in the first 5 minutes of life, or for CPAP if they have signs of respiratory distress after 5 minutes. The investigators will determine whether fewer participants who have the mask selectively applied receive PPV in the DR.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2020
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 24, 2020
CompletedFirst Posted
Study publicly available on registry
August 5, 2020
CompletedStudy Start
First participant enrolled
October 11, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 16, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
May 9, 2023
CompletedDecember 5, 2023
December 1, 2023
2.4 years
July 24, 2020
December 3, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
The proportion of participants who receive face mask PPV in the delivery room DR
The proportion of participants who receive face mask positive pressure ventilation (PPV) in the delivery room (DR)
Within 30 minutes of birth
Secondary Outcomes (23)
The proportion of participants who receive face mask CPAP in the first 5 minutes of life
5 minutes
The proportion of participants who receive face mask PPV in the first 5 minutes of life
5 minutes
HR at 5 minutes of life
5 minutes
SpO2 at 5 minutes of life
5 minutes
The proportion of participants who receive face mask CPAP in the DR
Within 30 minutes of birth
- +18 more secondary outcomes
Study Arms (2)
Routine face mask application
ACTIVE COMPARATORRoutine application of a face mask shortly after birth to deliver continuous positive airway pressure (CPAP)
Selective face mask application
EXPERIMENTALSelective application of a face mask to give positive pressure ventilation (PPV) for apnoea or bradycardia \[heart rate (HR) \< 100 beats per minute (bpm)\] at any time in the delivery room (DR); or to give CPAP for signs of respiratory distress after 5 minutes of life
Interventions
Face mask application for CPAP and/or PPV delivery
Eligibility Criteria
You may qualify if:
- Born before 32 weeks gestational age by best obstetric estimate
You may not qualify if:
- Infants with major congenital anomalies
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Maternity Hospital
Dublin, D02 YH21, Ireland
Related Publications (14)
Perlman JM, Wyllie J, Kattwinkel J, Wyckoff MH, Aziz K, Guinsburg R, Kim HS, Liley HG, Mildenhall L, Simon WM, Szyld E, Tamura M, Velaphi S; Neonatal Resuscitation Chapter Collaborators. Part 7: Neonatal Resuscitation: 2015 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations. Circulation. 2015 Oct 20;132(16 Suppl 1):S204-41. doi: 10.1161/CIR.0000000000000276. No abstract available.
PMID: 26472855BACKGROUNDO'Donnell CP, Kamlin CO, Davis PG, Morley CJ. Crying and breathing by extremely preterm infants immediately after birth. J Pediatr. 2010 May;156(5):846-7. doi: 10.1016/j.jpeds.2010.01.007. Epub 2010 Mar 16.
PMID: 20236659BACKGROUNDMurphy MC, McCarthy LK, O'Donnell CPF. Crying and breathing by new-born preterm infants after early or delayed cord clamping. Arch Dis Child Fetal Neonatal Ed. 2020 May;105(3):331-333. doi: 10.1136/archdischild-2018-316592. Epub 2019 May 13.
PMID: 31085675BACKGROUNDKatheria A, Arnell K, Brown M, Hassen K, Maldonado M, Rich W, Finer N. A pilot randomized controlled trial of EKG for neonatal resuscitation. PLoS One. 2017 Nov 3;12(11):e0187730. doi: 10.1371/journal.pone.0187730. eCollection 2017.
PMID: 29099872BACKGROUNDKuypers KLAM, Lamberska T, Martherus T, Dekker J, Bohringer S, Hooper SB, Plavka R, Te Pas AB. The effect of a face mask for respiratory support on breathing in preterm infants at birth. Resuscitation. 2019 Nov;144:178-184. doi: 10.1016/j.resuscitation.2019.08.043. Epub 2019 Sep 12.
PMID: 31521774BACKGROUNDMurphy MC, McCarthy LK, O'Donnell CPF. Initiation of respiratory support for extremely preterm infants at birth. Arch Dis Child Fetal Neonatal Ed. 2021 Mar;106(2):208-210. doi: 10.1136/archdischild-2020-319798. Epub 2020 Aug 26.
PMID: 32847832BACKGROUNDSubramaniam P, Ho JJ, Davis PG. Prophylactic nasal continuous positive airway pressure for preventing morbidity and mortality in very preterm infants. Cochrane Database Syst Rev. 2016 Jun 14;(6):CD001243. doi: 10.1002/14651858.CD001243.pub3.
PMID: 27315509BACKGROUNDSandri F, Ancora G, Lanzoni A, Tagliabue P, Colnaghi M, Ventura ML, Rinaldi M, Mondello I, Gancia P, Salvioli GP, Orzalesi M, Mosca F. Prophylactic nasal continuous positive airways pressure in newborns of 28-31 weeks gestation: multicentre randomised controlled clinical trial. Arch Dis Child Fetal Neonatal Ed. 2004 Sep;89(5):F394-8. doi: 10.1136/adc.2003.037010.
PMID: 15321956BACKGROUNDGoncalves-Ferri WA, Martinez FE, Caldas JP, Marba ST, Fekete S, Rugolo L, Tanuri C, Leone C, Sancho GA, Almeida MF, Guinsburg R. Application of continuous positive airway pressure in the delivery room: a multicenter randomized clinical trial. Braz J Med Biol Res. 2014 Feb;47(3):259-64. doi: 10.1590/1414-431X20133278. Epub 2014 Jan 29.
PMID: 24554040BACKGROUNDChernick V, Avery ME. Response of premature infants with periodic breathing to ventilatory stimuli. J Appl Physiol. 1966 Mar;21(2):434-40. doi: 10.1152/jappl.1966.21.2.434. No abstract available.
PMID: 5949048BACKGROUNDDolfin T, Duffty P, Wilkes D, England S, Bryan H. Effects of a face mask and pneumotachograph on breathing in sleeping infants. Am Rev Respir Dis. 1983 Dec;128(6):977-9. doi: 10.1164/arrd.1983.128.6.977.
PMID: 6650989BACKGROUNDFleming PJ, Levine MR, Goncalves A. Changes in respiratory pattern resulting from the use of a facemask to record respiration in newborn infants. Pediatr Res. 1982 Dec;16(12):1031-4. doi: 10.1203/00006450-198212000-00013.
PMID: 7155672BACKGROUNDRamet J, Praud JP, D'Allest AM, Dehan M, Gaultier C. Trigeminal airstream stimulation. Maturation-related cardiac and respiratory responses during REM sleep in human infants. Chest. 1990 Jul;98(1):92-6. doi: 10.1378/chest.98.1.92.
PMID: 2361419BACKGROUNDvan Vonderen JJ, Kleijn TA, Schilleman K, Walther FJ, Hooper SB, te Pas AB. Compressive force applied to a manikin's head during mask ventilation. Arch Dis Child Fetal Neonatal Ed. 2012 Jul;97(4):F254-8. doi: 10.1136/archdischild-2011-300336. Epub 2011 Dec 5.
PMID: 22147285BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Colm PF O'Donnell, PhD
National Maternity Hospital; University College Dublin
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- Masking of caregivers not feasible due to the nature of the intervention
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 24, 2020
First Posted
August 5, 2020
Study Start
October 11, 2020
Primary Completion
February 16, 2023
Study Completion
May 9, 2023
Last Updated
December 5, 2023
Record last verified: 2023-12
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, ICF, CSR
- Time Frame
- Data will be available after the primary report of the study has been published and will be available for 5 years
- Access Criteria
- Requests for data that are accompanied by a protocol that describes the nature and purpose of the study, the data that is required and how it will be analysed will be considered by the chief and principal investigators. Studies that are determined not to be contrary to partcipants' interests; and to be consistent with the purpose for which consent was given for the original study and methodologically sound may be approved
Anonymised data will be shared for studies approved by the chief and principal investigators